[Genetic aspects in pathogenesis and optimization of arterial hypertension pharmacotherapy].
Milotova
N M
NM
Shikh
E V
EV
D000818:Animals; D002112:Calcifediol / Q000627:therapeutic use; D002762:Cholecalciferol / Q000627:therapeutic use; D005260:Female; D005838:Genotype; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology / Q000235:genetics*; D008297:Male; D051379:Mice; D011110:Polymorphism, Genetic; D018167:Receptors, Calcitriol / Q000235:genetics*; D012083:Renin / Q000378:metabolism; D012307:Risk Factors; D014807:Vitamin D / Q000031:analogs & derivatives / Q000378:metabolism / Q000627:therapeutic use*; D014808:Vitamin D Deficiency / Q000150:complications / Q000235:genetics
D018167:Receptors, Calcitriol; D014807:Vitamin D; D002762:Cholecalciferol; C104450:25-hydroxyvitamin D; D012083:Renin; D002112:Calcifediol